FI931061A7 - Metylen-oxindolderivat och foerfarande foer deras framstaellning - Google Patents

Metylen-oxindolderivat och foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI931061A7
FI931061A7 FI931061A FI931061A FI931061A7 FI 931061 A7 FI931061 A7 FI 931061A7 FI 931061 A FI931061 A FI 931061A FI 931061 A FI931061 A FI 931061A FI 931061 A7 FI931061 A7 FI 931061A7
Authority
FI
Finland
Prior art keywords
oxindolderivat
methylene
foerfarande foer
och foerfarande
deras framstaellning
Prior art date
Application number
FI931061A
Other languages
English (en)
Finnish (fi)
Other versions
FI931061A0 (fi
Inventor
Franco Buzzetti
Antonio Longo
Maristella Colombo
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI931061A7 publication Critical patent/FI931061A7/fi
Publication of FI931061A0 publication Critical patent/FI931061A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI931061A 1991-07-12 1993-03-10 Metylen-oxindolderivat och foerfarande foer deras framstaellning FI931061A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919115160A GB9115160D0 (en) 1991-07-12 1991-07-12 Methylen-oxindole derivatives and process for their preparation
PCT/EP1992/001569 WO1993001182A1 (en) 1991-07-12 1992-07-10 Methylen-oxindole derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
FI931061A7 true FI931061A7 (fi) 1993-03-10
FI931061A0 FI931061A0 (fi) 1993-03-10

Family

ID=10698323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931061A FI931061A0 (fi) 1991-07-12 1993-03-10 Metylen-oxindolderivat och foerfarande foer deras framstaellning

Country Status (22)

Country Link
US (1) US5409949A (enExample)
EP (2) EP0525472A3 (enExample)
JP (1) JP3188701B2 (enExample)
KR (1) KR930702337A (enExample)
AT (1) ATE206420T1 (enExample)
AU (1) AU656015B2 (enExample)
CA (1) CA2091058C (enExample)
DE (1) DE69232093T2 (enExample)
DK (1) DK0552329T3 (enExample)
ES (1) ES2165357T3 (enExample)
FI (1) FI931061A0 (enExample)
GB (1) GB9115160D0 (enExample)
HU (1) HUT67496A (enExample)
IE (1) IE922253A1 (enExample)
IL (1) IL102383A (enExample)
MX (1) MX9204008A (enExample)
NZ (1) NZ243454A (enExample)
PT (1) PT552329E (enExample)
RU (1) RU2072989C1 (enExample)
TW (1) TW202444B (enExample)
WO (1) WO1993001182A1 (enExample)
ZA (1) ZA925169B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
US5587385A (en) * 1991-12-24 1996-12-24 Farmitalia Carlo Erba S.R.L. Arylidene-heterocyclic derivatives and process for their preparation
GB9313638D0 (en) * 1993-07-01 1993-08-18 Erba Carlo Spa Arylidene and heteroarylidene oxindole derivatives and process for their preparation
GB9326136D0 (en) * 1993-12-22 1994-02-23 Erba Carlo Spa Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
GB9406137D0 (en) * 1994-03-28 1994-05-18 Erba Carlo Spa N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
GB9412719D0 (en) * 1994-06-24 1994-08-17 Erba Carlo Spa Substituted azaindolylidene compounds and process for their preparation
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6147106A (en) * 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
EP1247803A3 (en) * 1996-08-23 2002-10-16 Sugen, Inc. Indolinone compounds suitable for modulation of protein kinases
WO1998024432A2 (en) * 1996-12-05 1998-06-11 Sugen, Inc. Use of indolinone compounds as modulators of protein kinases
US6051597A (en) * 1997-06-13 2000-04-18 Merck & Co., Inc. Indolylquinones as antidiabetic agents
US20040067531A1 (en) * 1997-08-20 2004-04-08 Sugen, Inc. Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
CA2321307A1 (en) 1998-02-27 1999-09-02 Venkatachala L. Narayanan Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
US6102942A (en) 1998-03-30 2000-08-15 Endovascular Technologies, Inc. Stent/graft deployment catheter with a stent/graft attachment mechanism
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
CA2383623A1 (en) * 1998-08-04 2000-02-17 Sugen, Inc. 3-methylidenyl-2-indolinone modulators of protein kinase
US6680335B2 (en) 1998-09-28 2004-01-20 Sugen, Inc. Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
BR9916324A (pt) 1998-12-17 2001-10-02 Hoffmann La Roche 4,5-pirazinoxindóis como inibidores de proteìna quinase
US6153634A (en) * 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
JP2002532493A (ja) 1998-12-17 2002-10-02 エフ．ホフマン−ラ ロシュ アーゲー Ｊｎｋプロテインキナーゼ阻害剤としての４−アリールオキシインドール
EP1157019B1 (en) * 1998-12-17 2003-03-19 F. Hoffmann-La Roche Ag 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
JP2000247949A (ja) * 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
JP2002540096A (ja) * 1999-03-24 2002-11-26 スージェン・インコーポレーテッド キナーゼ阻害剤としてのインドリノン化合物
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
ES2341843T3 (es) 2000-02-03 2010-06-29 EISAI R&D MANAGEMENT CO., LTD. Inhibidores de la expresion de integrina.
US6573293B2 (en) 2000-02-15 2003-06-03 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
MY128449A (en) 2000-05-24 2007-02-28 Sugen Inc Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
US6706709B2 (en) 2000-06-02 2004-03-16 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP2005508953A (ja) 2001-10-10 2005-04-07 スージェン・インコーポレーテッド キナーゼ阻害剤としての３−［４−（置換ヘテロサイクリル）−ピロール−２−イルメチリデン］−２−インドリノン誘導体
EP1481678A4 (en) * 2002-03-05 2009-12-30 Eisai R&D Man Co Ltd ANTITUMORAL AGENT CONTAINING A SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND AND AN ANGIOGENESIS INHIBITOR
US20050107819A1 (en) * 2003-11-14 2005-05-19 Medtronic Vascular, Inc. Catheter with a sectional guidewire shaft
US8772269B2 (en) * 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2010149943A1 (en) * 2009-06-25 2010-12-29 Oncorel Ab New compounds and medical use
CN103274988B (zh) * 2013-06-20 2016-04-13 河北大学 3-(氰基-p-硝基苯甲撑基)-2-吲哚酮衍生物及其合成方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3310891A1 (de) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
JPH03213847A (ja) * 1990-01-18 1991-09-19 Konica Corp ハロゲン化銀写真感光材料
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation

Also Published As

Publication number Publication date
NZ243454A (en) 1995-02-24
DE69232093T2 (de) 2002-05-16
CA2091058C (en) 2004-03-30
DE69232093D1 (de) 2001-11-08
WO1993001182A1 (en) 1993-01-21
JPH06501494A (ja) 1994-02-17
PT552329E (pt) 2002-02-28
KR930702337A (ko) 1993-09-08
GB9115160D0 (en) 1991-08-28
IE922253A1 (en) 1993-01-13
EP0552329A1 (en) 1993-07-28
EP0525472A3 (en) 1993-02-24
US5409949A (en) 1995-04-25
TW202444B (enExample) 1993-03-21
CA2091058A1 (en) 1993-01-13
HU9300723D0 (en) 1993-06-28
HUT67496A (en) 1995-04-28
EP0552329B1 (en) 2001-10-04
AU2277792A (en) 1993-02-11
FI931061A0 (fi) 1993-03-10
IL102383A0 (en) 1993-01-14
MX9204008A (es) 1993-01-01
ATE206420T1 (de) 2001-10-15
AU656015B2 (en) 1995-01-19
JP3188701B2 (ja) 2001-07-16
RU2072989C1 (ru) 1997-02-10
EP0525472A2 (en) 1993-02-03
ZA925169B (en) 1993-04-28
DK0552329T3 (da) 2001-11-12
IL102383A (en) 1997-09-30
ES2165357T3 (es) 2002-03-16

Similar Documents

Publication Publication Date Title
FI934811L (fi) Stabiliserade enzymer och detergentfoereningar
FI921968L (fi) Flerlagrade monolitiska magnetiska komponenter och deras framstaellning
FI921105L (fi) Segmentpolyteramider och deras syntesprocess
FI934078A0 (fi) Haorvaordskompositioner innehaollande formgivnings/konditionerings-medel och mjukgoeringsmedel
FI931061A7 (fi) Metylen-oxindolderivat och foerfarande foer deras framstaellning
FI925427L (fi) Styrkrets och foerfarande foer transmissionsutgaong
FI925533L (fi) Tantal- eller niobbaserad perovskit och foerfarande foer framstaellning daerav
FI923227A7 (fi) Hopsaettbar reglerbar faotoelj och foerfarande
FI924747A0 (fi) Peg-imidat och proteinderivat daerav
FI924966L (fi) Stabila polyamidhartsdispersioner och foerfarande foer deras framstaellning
FI934328L (fi) Foerfarande och anordning foer nqr-testning
FI912760A7 (fi) Skivfilter och filterelement foer skivfilter
FI923971L (fi) Bundna fiberbelaeggningssubstrater och foerfarande foer framstaellning daerav
FI923017A7 (fi) Farmakologiskt verksamma hydrazinderivat och foerfarande foer deras framstaellning
FI921940L (fi) Stabila pura-vektorer och deras anvaendning
FI930112A7 (fi) Koppar-inehaollande organometalliska komplex och dessa innehaollande koncentrat och dieseloljor
FI921818L (fi) Hopknippningsanordning och foerfarande
FI925976L (fi) Termiskt stabila kompositioner och dessa innehaollande smoerjmedel och funktionella vaetskor
FI925234L (fi) Stabila polyamidhartsmikrodispersioner och foerfaranden foer deras framstaellning
FI924886A7 (fi) Saenkbart vaetskenivaomaetningssystem och anvaendningsfoerfarande
FI922920A7 (fi) Separationsfoerfarande och anordning haerfoer
FI921741L (fi) En katalyt och belaeggningskomposition innehaollande densamma
FI925776L (fi) Oeverbasiska alkalmetallsalter och foerfaranden foer deras framstaellning
FI934187L (fi) Icke-foervraengda polyetenskumstrukturer och framstaellningsfoerfarande
FI924083A7 (fi) Spaenningsdeviationkompensator foer slaecktid foer vaexelriktare och omformare

Legal Events

Date Code Title Description
FD Application lapsed